| P2093 | author name string | Qi Zhao | |
| | Chan Hum Park | |
| | Kinzo Matsumoto | |
| | Noriko Yamabe | |
| | Hyun Young Kim | |
| | Takako Yokozawa | |
| | Jeong Sook Noh | |
| P2860 | cites work | Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells | Q24561820 |
| | Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B | Q28208638 |
| | The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor | Q28238069 |
| | The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity | Q28241306 |
| | The protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model | Q28583489 |
| | Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene | Q28584842 |
| | Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes | Q28646399 |
| | Regulation of the mevalonate pathway | Q29547763 |
| | Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation | Q34338138 |
| | Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes | Q34953482 |
| | Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes | Q35022159 |
| | Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? | Q35034481 |
| | Nuclear factor kappa B--molecular biomedicine: the next generation | Q35844205 |
| | Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes | Q35923385 |
| | Oxidative stress and antioxidant treatment in diabetes | Q36064410 |
| | Molecular and anatomical determinants of central leptin resistance | Q36108714 |
| | Obesity: Changes in lipid metabolism and the role of insulin | Q37074466 |
| | Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. | Q37382401 |
| | Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice | Q38290693 |
| | Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver | Q38297185 |
| | Endothelial dysfunction and vascular inflammation in type 2 diabetes: interaction of AGE/RAGE and TNF-alpha signaling | Q42406006 |
| | Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes | Q43833528 |
| | Determination of malonaldehyde precursor in tissues by thiobarbituric acid test | Q44764466 |
| | Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats. | Q46034846 |
| | Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes | Q46620651 |
| | Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. | Q51466692 |
| | Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice. | Q51475764 |
| | Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evidence for polygenic control. | Q51619645 |
| | Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice. | Q51630317 |
| P433 | issue | 1 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| | dyslipidemia | Q66291209 |
| P304 | page(s) | 111-119 | |
| P577 | publication date | 2010-10-11 | |
| P1433 | published in | Journal of Pharmacy and Pharmacology | Q10532762 |
| P1476 | title | Chinese prescription Kangen-karyu prevents dyslipidaemia and oxidative stress in mouse model of type 2 diabetes. | |
| P478 | volume | 63 | |